February 10, 2026 | 12:00 p.m. - 1:15 p.m. EST | Room 106
Thomas Michael Menino Convention & Exhibition Center (MCEC) Boston, MA, USA
Join SCIEX for an energizing afternoon at SLAS 2026 with a special seminar featuring our product manager, product specialist, and scientists from Pfizer and BMS. Discover the latest news about the SCIEX Echo® MS+ system and ask questions to the people who developed it.
Hear firsthand from the innovators and gain exclusive insights into how the development team work with pharmaceutical companies to drive new features and innovations for efficiency, reproducibility, and scientific impact.
Joining the team from SCIEX will be Alandra Quinn and Andrew Wanger who run the system everyday. They will also be available to answer questions about their experience of the system.
Lunch served | Ideas shared | Latest innovation unveiled
Alandra Quinn
Global Reasearch and Development, Pfizer
Alandra Quinn is a Scientist within Medicine Design at Pfizer, where she develops high-throughput mass spectrometry workflows to accelerate drug discovery. Her work advancing acoustic ejection mass spectrometry has expanded it user in quality control, metal detection, and direct-to-biology applications – supporting faster and more informed decisions in medicinal chemistry using AEMS.
Kean Woodmansey
Senior Product Manager, Echo® MS+ system
Kean Woodmansey is the Senior Product Manager for the Echo® MS system at SCIEX. In this role, he is responsible for the strategic success of the Echo MS+ portfolio. Kean spent the first part of his career working in contract research organizations, doing bioanalysis, before moving into pharma market development and product management.
Nick Herold
Echo® MS Excellence Team
Nick Herold is responsible for business development efforts related to the Sciex EchoMS+ technology in the Americas since 2022. During this time, he aided in the successful launch of a new product offering resulting in the first global sale of EchoMS+ as well as contributing significantly as it relates to product placements and associated revenue generation. Prior to joining Sciex – a Danaher company, Nick spent time on business development, sales, and marketing at several global companies, including Taconic Biosciences, Thermo Fisher Scientific – Life Technologies, and Perfinity Biosciences. Nick holds a Bachelor of Science degree in biology-chemistry from Saint Joseph’s College in Indiana and an MBA from the University of Notre Dame. He is a multi-patent holder and has enrolled in professional development at Harvard.
Andrew Wagner
Sr. Principal Scientist, Bristol Myers Squibb
Andrew Wagner is a dedicated research scientist based in Princeton, NJ, with over fifteen years of industry experience specializing in high-throughput mass spectrometry method development. He currently serves as Senior Principal Scientist on the Lead Discovery and Optimization team at Bristol Myers Squibb, where he provides quantitative bioanalytical support for in vitro ADME profiling assays and leads the development and implementation of cutting-edge MS-based analytical methods—including acoustic ejection (AE)-MS/MS, SPE-MS/MS, and LC-MS/MS—to advance drug discovery, expand ADME/Tox profiling capabilities, and incorporate HTMS into HTS workflows for hit identification.
Andrew holds a Bachelor of Science in Biochemistry from UCLA and is a named inventor on two U.S. patents for methods and systems in quantitative bioanalysis.